An exon-skipping antisense medicine for Duchenne muscular dystrophy
Viltolarsen
A specialist injection used for a particular form of Duchenne muscular dystrophy suitable for exon-53 skipping.
What is Viltolarsen?
Viltolarsen is a specialist medicine used to treat Duchenne muscular dystrophy, an inherited muscle-wasting condition, in people whose particular gene change is suitable for what is called exon-53 skipping. It is an antisense medicine given as an injection into a vein, usually each week. It helps the body make a more useful form of a muscle protein called dystrophin. It is generally well tolerated, and the main thing watched for is the effect on the kidneys, so regular kidney tests are done. It is prescribed and supervised by a specialist team.
Education and reference only. This is a plain-language guide to Viltolarsen — it deliberately contains no doses. Doses depend on the person, the brand and the reason for treatment, and belong with your prescriber. Always check the BNF, the product labelling (SmPC) and follow medical advice.
What it is
Viltolarsen is a medicine used for Duchenne muscular dystrophy, an inherited condition that causes progressive muscle weakness, mainly in boys. It is a type of medicine called an antisense oligonucleotide and only suits people whose specific gene change can be helped by a process called exon-53 skipping, so genetic testing is needed first. It is given as an injection into a vein, usually once a week, in a healthcare setting. It is a specialist treatment, started and supervised by a team experienced in Duchenne muscular dystrophy.
How it works
Duchenne muscular dystrophy is caused by changes in the gene for dystrophin, a protein that helps keep muscle fibres strong; without working dystrophin, muscles gradually break down. Viltolarsen works by helping the body 'skip over' a faulty part of the genetic message (exon 53) when it reads the gene, so it can produce a shorter but more useful form of dystrophin. Having some working dystrophin is thought to help slow the muscle damage. Because it works on the genetic message, it only helps people whose particular gene change is suitable for skipping exon 53, and it is given regularly to keep the effect going.
Company & origin
Originated / developed by: Specialist manufacturer.
A specialist medicine used for a particular form of Duchenne muscular dystrophy that is suitable for exon-53 skipping, given by injection into a vein.
Practical use
How to take Viltolarsen
General, dose-free guidance — always follow your prescriber's and the leaflet's specific instructions.
- It is given by a healthcare professional as an injection into a vein, usually once a week; you do not take it yourself.
- Keep all your appointments, as it is given regularly and needs ongoing monitoring.
- Have the regular kidney tests your team arranges, as the kidneys are the main thing watched.
- Tell your team about any change in how much urine you pass, or any swelling.
- Continue your other Duchenne care, such as physiotherapy and regular heart and breathing checks.
Weighing it up
Advantages & disadvantages of Viltolarsen
Advantages
- Helps the body make a more useful form of dystrophin in suitable people with Duchenne muscular dystrophy.
- Generally well tolerated.
- Offers a specific, targeted approach for people whose gene change suits exon-53 skipping.
Disadvantages
- Only helps the people whose gene change is suitable for exon-53 skipping.
- Given as a regular injection into a vein, which means ongoing clinic visits.
- Needs regular kidney monitoring during treatment.
Practical use
Good to know
The first thing to know is that viltolarsen only helps people whose specific gene change is suitable for exon-53 skipping, so genetic testing confirms suitability before treatment. It is given as an injection into a vein, usually each week, so it involves regular hospital or clinic visits. It is generally well tolerated. The main safety point to monitor is its possible effect on the kidneys: with this kind of medicine, kidney function is checked regularly, and any change in how much you pass urine, or swelling, should be reported. It is used as part of overall care for Duchenne muscular dystrophy, which includes physiotherapy, other medicines and regular reviews of heart, breathing and muscle function. The specialist team explains what to expect and monitors closely.
Who should not take it / use with caution
- People who have had a serious allergic reaction to viltolarsen should not have it.
- It is only for people whose gene change is confirmed to be suitable for exon-53 skipping.
- It is used with care in people with kidney problems, with regular monitoring, under specialist supervision.
Monitoring
- Genetic testing to confirm the gene change is suitable for exon-53 skipping before starting.
- Regular kidney tests during treatment.
- Reviewing muscle, heart and breathing function as part of overall Duchenne care.
Side effects
- It is generally well tolerated, with cough, cold-like symptoms or bruising in some people.
- Reactions related to the injection, such as redness or discomfort.
- Rarely, changes in kidney tests, which regular monitoring is designed to catch.
Key interactions
- There are few well-established routine medicine interactions, but tell your team about everything you take.
- Medicines that can affect the kidneys may need reviewing, given the focus on kidney monitoring.
- It is used alongside the rest of Duchenne care under specialist guidance.
Available as: A solution given by injection into a vein.
Answers
Viltolarsen: frequently asked questions
What is viltolarsen used for?
It is used to treat Duchenne muscular dystrophy in people whose specific gene change is suitable for what is called exon-53 skipping.
Who can have it?
Only people whose gene change is suitable for exon-53 skipping can benefit, so genetic testing is done to confirm this before treatment.
How is it given?
It is given by a healthcare professional as an injection into a vein, usually once a week, so it involves regular clinic visits.
Is it well tolerated?
It is generally well tolerated; the main thing watched for is its possible effect on the kidneys, so regular kidney tests are done.
Does it cure Duchenne muscular dystrophy?
No. It does not cure the condition, but it helps the body make a more useful form of dystrophin, which is thought to help slow muscle damage in suitable people.
Authoritative sources
- BNF
- NICE CKS
Building a medicines information resource?
We create evidence-led, dose-free drug and formulary references for teams.